BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9130643)

  • 1. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system.
    Taupin V; Renno T; Bourbonnière L; Peterson AC; Rodriguez M; Owens T
    Eur J Immunol; 1997 Apr; 27(4):905-13. PubMed ID: 9130643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
    J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE.
    Renno T; Taupin V; Bourbonnière L; Verge G; Tran E; De Simone R; Krakowski M; Rodriguez M; Peterson A; Owens T
    Mol Cell Neurosci; 1998 Dec; 12(6):376-89. PubMed ID: 9888990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
    Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
    J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
    Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
    Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model.
    Almolda B; Costa M; Montoya M; González B; Castellano B
    J Neuroimmunol; 2009 Apr; 209(1-2):65-80. PubMed ID: 19246105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and its receptors contribute to apoptosis of oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy) sustaining chronic mechanical compression.
    Inukai T; Uchida K; Nakajima H; Yayama T; Kobayashi S; Mwaka ES; Guerrero AR; Baba H
    Spine (Phila Pa 1976); 2009 Dec; 34(26):2848-57. PubMed ID: 19949368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
    Selmaj K; Raine CS; Cross AH
    Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination.
    Hisahara S; Araki T; Sugiyama F; Yagami Ki; Suzuki M; Abe K; Yamamura K; Miyazaki J; Momoi T; Saruta T; Bernard CC; Okano H; Miura M
    EMBO J; 2000 Feb; 19(3):341-8. PubMed ID: 10654933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP; Piddlesden S; Morgan BP; Reynolds R
    Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
    Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
    Ponomarev ED; Shriver LP; Maresz K; Dittel BN
    J Neurosci Res; 2005 Aug; 81(3):374-89. PubMed ID: 15959904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
    Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
    Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis.
    Bauer J; Huitinga I; Zhao W; Lassmann H; Hickey WF; Dijkstra CD
    Glia; 1995 Dec; 15(4):437-46. PubMed ID: 8926037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.
    Akassoglou K; Bauer J; Kassiotis G; Pasparakis M; Lassmann H; Kollias G; Probert L
    Am J Pathol; 1998 Sep; 153(3):801-13. PubMed ID: 9736029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.
    Liedtke W; Cannella B; Mazzaccaro RJ; Clements JM; Miller KM; Wucherpfennig KW; Gearing AJ; Raine CS
    Ann Neurol; 1998 Jul; 44(1):35-46. PubMed ID: 9667591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.